Get my own profile
Public access
View all72 articles
8 articles
available
not available
Based on funding mandates
Co-authors
- Marina BacacRocheVerified email at roche.com
- Guy GeorgesRoche Innovation Center MunichVerified email at roche.com
- Ulrich BrinkmannRocheVerified email at roche.com
- Hubert KettenbergerVerified email at roche.com
- Sara ColombettiRoche Innovation Center Zurich-pREDVerified email at roche.com
- Alfred ZippeliusProfessor of Translational Oncology, Co-Head Medical OncologyVerified email at usb.ch
- Manfred SchwaigerHead of Operations, pRED Oncology, F. Hoffman-LaRoche Ltd.Verified email at roche.com
- Daniela Stefanie ThommenDivision of Molecular Oncology and Immunology, The Netherlands Cancer InstituteVerified email at nki.nl
- Andreas RollerRoche Pharma Research and Early Development (pRED)Verified email at roche.com
- stefan endresLudwig-Maximilians-UniversitätVerified email at lmu.de
- Lyubomir (Lubo) VassilevEMD Serono Research & Development Institute, Inc.Verified email at emdserono.com
- Horst KesslerVerified email at tum.de
- MJS DyerErnest and Helen Scott Haematological Research Institute, University of LeicesterVerified email at leicester.ac.uk
- Tapan NayakMerckVerified email at merck.com
- Mark CraggCentre for Cancer Immunology, University of SouthamptonVerified email at soton.ac.uk
- Jean Jacques FourniéCentre de Recherches en Cancérologie de Toulouse, Universitré de Toulouse, PRESVerified email at inserm.fr
- Ysebaert LoicHematologistVerified email at iuct-oncopole.fr
- Alexander BujotzekRoche Innovation Center MunichVerified email at roche.com
- Johannes BuchnerTUM Technical University of MunichVerified email at tum.de
- Dr. Peter SondermannTacalyx GmbHVerified email at tacalyx.com
Follow
Christian Klein
Roche Pharma Research and Early Development, Roche Innovation Center Zurich
Verified email at roche.com